Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-18

Clinical Trial Update: INF-α Innate Immune Response to Gliadin

View source ↗

Summary

Completed clinical trial investigating the innate immune response to gliadin in celiac disease, focusing on interferon-alpha pathways.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Federico II University | Conditions: Celiac Disease | Status: COMPLETED